Drugs / PanCytoVir™
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06025344 | Sep 2024 | — | TrippBio, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PanCytoVir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06025344 ↗ |
| Route | Oral | “Single oral dose of 1000 mg (100 mg/mL) under fasted conditions” NCT06025344 ↗ |